Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas

British Journal of Cancer

Volumn 79, Issue 5-6, 1999, Pages 754-758

  Freihoff, D ^a   Kempe, A ^a   Beste, B ^a   Wappenschmidt, B ^a   Kreyer, E ^a   Hayashi, Y ^a   Meindl, A ^b   Krebs, D ^a   Wiestler, O D ^a   Von Deimling, A ^a   Schmutzler, R K ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Breast cancer; LOH10q; Mutations; PTEN MMAC1 TEP1; Tumour suppressor gene

Indexed keywords

DNA; MICROSATELLITE DNA; PRIMER DNA;

ALLELE; ARTICLE; BREAST CARCINOMA; CANCER FAMILY; CHROMOSOME 10Q; CODON; CONSTITUTIVE HETEROCHROMATIN; CONTROLLED STUDY; DELETION MUTANT; FEMALE; GENE LOSS; GENE MUTATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0033001584     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690121     Document Type: Article

References (34)

1. Bender B, Wiestler OD and Von Deimling A (1994) A device for processing large acrylamide gels. Biotechniques 16: 204-206
2. Bloom HJ and Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1049 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377
3. Bocker T, Diermann J, Friedl W, Gebert J, Holinski-Feder E, Karner-Hanusch J, von Knebel-Doeberitz M, Koelble K, Moeslein G, Schackert HK, Wirtz HC, Fishel R and Ruschoff J (1997) Microsatellite instability analysis: a multicenter study for reliability and quality control. Cancer Res 57: 4739-4743
4. Bostroem J, Cobbers JMJL, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP and Reifenberger G (1998) Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome 10q. Cancer Res 58: 29-33
5. Chen J, Lindblom P and Lindblom A (1998) A study of the PTEN/MMAC1 gene in 136 breast cancer families. Hum Genet 102: 124-125
6. Dahia LM, FitzGerald MG, Zhang X, Marsh DJ, Zheng Z, Pietsch T, von Deimling A, Haluska FG, Haber DA and Eng C (1998) A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene 16: 2403-2406
7. Duerr EM, Rollbrocker B, Hayashi Y, Peters N, Meyer-Putlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C and von Deimling A (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 15: 2254-2259
8. Fearon ER (1997) Human cancer syndromes: clues to the origin and nature of cancer. Science 278: 1043-1050
9. Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin AF and Zeuthen J (1997) Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660-3663
10. Hayashi Y, Ueki K, Waha A, Wiestler OD, Louis DN and von Deimling A (1997) Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme. Brain Pathol 7: 871-875
11. Kerangueven F, Eisinger F, Noguchi T, Allione F, Wargniez V, Eng C, Padberg G, Theillet C, Jacquemier J, Longy M, Sobol H and Birnbaum D (1997) Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene 14: 339-347
12. Kong D, Suzuki A, Zou TT, Sakurada A, Kemp LW, Wakatsuki S, Yokoyama T, Yamakawa H, Furukawa T, Sato M, Ohuchi N, Sato S, Yin J, Wang S, Abraham JM, Souza RF, Smolinski KN, Meltzer SJ and Horii A (1997) PTEN1 is frequently mutated in primary endometrial carcinomas (letter). Nat Genet 17: 143-144
13. Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR and Futreal PA (1996) BRCA2 mutations in primary breast and ovarian cancers. Nat Genet 13: 238-240
14. Li DM and Sun H (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57: 2124-2129
15. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer (see comments). Science 275: 1943-1947
16. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C and Parsons R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16: 64-67
17. Miki Y, Swensen J, Shattuck Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattler T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett C, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71
18. Miki Y, Katagiri T, Kasumi F, Yoshimoto T and Nakamura Y (1996) Mutation analysis in the BRCA2 gene in primary breast cancers. Nat Genet 13: 245-247
19. Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH, Woods DG, Mariman EC, Padberg GW and Kremer H (1997) Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 6: 1383-1387
20. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD and Bigner SH (1997) PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57: 4187-4190
21. Remmele W, Hildebrand U, Hienz HA, Klein PJ, Vierbuchen M, Behnken LJ, Heicke B and Scheidt E (1986) Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch A Pathol Anat Histopathol 409: 127-147
22. Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI and Boyd J (1997) Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 57: 3657-3659
23. Schmutzler RK, Bierhoff E, Werkhausen T, Fimmers R, Speiser P, Kubista E, Krebs D, Zeillinger R, Wiestler OD and Von Deimling A (1997) Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma. Int J Cancer 74: 322-325
24. Singh B, Ittmann MM and Krolewski JJ (1998) Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosomes Cancer 21: 166-171
25. Sourvinos G, Kiaris H, Tsikkinis A, Vassilaros S and Spandidos DA (1997) Microsatellite instability and loss of heterozygosity in primary breast tumours. Tumour Biol 18: 157-166
26. Spiessl B, Beahrs OB and Hermanek P (1990) UICC TNM Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors. Springer Verlag: Berlin
27. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH and Tavtigian SV (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362
28. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R and Ellenson LH (1997) Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57: 3935-3940
29. Tsou HC, Teng DH, Ping XL, Brancolini V, Davis T, Hu R, Xie XX, Gruener AC, Schrager CA, Christiano AM, Eng C, Steck P, Ott J, Tavtigian SV and Peacocke M (1997) The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases (in process citation). Am J Hum Genet 61: 1036-1043
30. Ueda K, Nishijima M, Inui H, Watatani M, Yayoi E, Okamura J, Yasutomi M, Nakamura Y and Miyoshi Y (1998) Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers. Jpn J Cancer Res 89: 17-21
31. von Deimling A, Bender B, Louis DN and Wiestler OD (1993) A rapid and non-radioactive PCR based assay for the detection of allelic loss in human gliomas. Neuropathol Appl Neurobiol 19: 524-529
32. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D and Parsons R (1997) Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57: 4183-4186
33. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C and Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2 (see comments) [published erratum appears in Nature (1996) 379: 749]. Nature 378: 789-792
34. World Health Organization (1981) Histological Typing of Breast Tumours. 2nd International Classification of Tumors. World Health Organization: Geneva